SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-17-000668
Filing Date
2017-02-14
Accepted
2017-02-14 16:55:01
Documents
64
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2230877z10-q.htm 10-Q 545922
2 EX-31.1 a2230877zex-31_1.htm EX-31.1 7689
3 EX-31.2 a2230877zex-31_2.htm EX-31.2 7612
4 EX-32.1 a2230877zex-32_1.htm EX-32.1 4549
5 EX-32.2 a2230877zex-32_2.htm EX-32.2 4502
  Complete submission text file 0001047469-17-000668.txt   4862068

Data Files

Seq Description Document Type Size
6 EX-101.INS ctrv-20161231.xml EX-101.INS 1151503
7 EX-101.SCH ctrv-20161231.xsd EX-101.SCH 55086
8 EX-101.CAL ctrv-20161231_cal.xml EX-101.CAL 39322
9 EX-101.DEF ctrv-20161231_def.xml EX-101.DEF 224311
10 EX-101.LAB ctrv-20161231_lab.xml EX-101.LAB 452106
11 EX-101.PRE ctrv-20161231_pre.xml EX-101.PRE 332276
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 17609883
SIC: 2834 Pharmaceutical Preparations